Annual Operating Profit:
$4.09B-$141.50M(-3.34%)Summary
- As of today, REGN annual operating income is $4.09 billion, with the most recent change of -$141.50 million (-3.34%) on December 31, 2024.
- During the last 3 years, REGN annual operating profit has fallen by -$4.90 billion (-54.51%).
- REGN annual operating profit is now -54.51% below its all-time high of $8.99 billion, reached on December 31, 2021.
Performance
REGN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
$1.08B+$487.80M(+82.44%)Summary
- As of today, REGN quarterly operating income is $1.08 billion, with the most recent change of +$487.80 million (+82.44%) on June 30, 2025.
- Over the past year, REGN quarterly operating profit has increased by +$9.90 million (+0.93%).
- REGN quarterly operating profit is now -67.75% below its all-time high of $3.35 billion, reached on June 30, 2021.
Performance
REGN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
$3.84B+$9.90M(+0.26%)Summary
- As of today, REGN TTM operating income is $3.84 billion, with the most recent change of +$9.90 million (+0.26%) on June 30, 2025.
- Over the past year, REGN TTM operating profit has dropped by -$64.00 million (-1.64%).
- REGN TTM operating profit is now -57.76% below its all-time high of $9.09 billion, reached on March 31, 2022.
Performance
REGN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
REGN Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -3.3% | +0.9% | -1.6% |
| 3Y3 Years | -54.5% | -2.7% | -44.0% |
| 5Y5 Years | +85.2% | +64.5% | +24.5% |
REGN Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -54.5% | at low | -11.8% | +82.4% | -38.4% | +0.3% |
| 5Y | 5-Year | -54.5% | +85.2% | -67.8% | +82.4% | -57.8% | +24.5% |
| All-Time | All-Time | -54.5% | +2094.4% | -67.8% | +1889.7% | -57.8% | +1972.2% |
REGN Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.08B(+82.4%) | $3.84B(+0.3%) |
| Mar 2025 | - | $591.70M(-40.2%) | $3.83B(-4.0%) |
| Dec 2024 | $4.09B(-3.3%) | $990.20M(-16.0%) | $3.99B(+0.4%) |
| Sep 2024 | - | $1.18B(+10.3%) | $3.97B(+1.8%) |
| Jun 2024 | - | $1.07B(+42.3%) | $3.90B(+1.4%) |
| Mar 2024 | - | $751.40M(-22.8%) | $3.85B(-4.8%) |
| Dec 2023 | $4.23B(-15.2%) | $972.90M(-12.4%) | $4.05B(-4.1%) |
| Sep 2023 | - | $1.11B(+9.3%) | $4.22B(-2.6%) |
| Jun 2023 | - | $1.02B(+7.4%) | $4.33B(-2.1%) |
| Mar 2023 | - | $946.70M(-17.4%) | $4.43B(-6.6%) |
| Dec 2022 | $4.99B(-44.5%) | $1.15B(-6.3%) | $4.74B(-24.0%) |
| Sep 2022 | - | $1.22B(+10.3%) | $6.23B(-9.1%) |
| Jun 2022 | - | $1.11B(-11.8%) | $6.86B(-24.6%) |
| Mar 2022 | - | $1.26B(-52.3%) | $9.09B(+1.6%) |
| Dec 2021 | $8.99B(+151.5%) | $2.64B(+42.9%) | $8.95B(+19.7%) |
| Sep 2021 | - | $1.85B(-44.8%) | $7.47B(+11.9%) |
| Jun 2021 | - | $3.35B(+200.8%) | $6.68B(+67.5%) |
| Mar 2021 | - | $1.11B(-4.7%) | $3.99B(+11.5%) |
| Dec 2020 | $3.58B(+61.9%) | $1.17B(+10.8%) | $3.58B(+15.9%) |
| Sep 2020 | - | $1.05B(+60.4%) | $3.09B(+11.4%) |
| Jun 2020 | - | $656.40M(-6.2%) | $2.77B(+14.0%) |
| Mar 2020 | - | $700.10M(+3.6%) | $2.43B(+10.0%) |
| Dec 2019 | $2.21B(-12.8%) | $675.70M(-8.5%) | $2.21B(-1.9%) |
| Sep 2019 | - | $738.50M(+134.0%) | $2.25B(+5.2%) |
| Jun 2019 | - | $315.60M(-34.3%) | $2.14B(-12.5%) |
| Mar 2019 | - | $480.00M(-33.2%) | $2.45B(-3.4%) |
| Dec 2018 | $2.53B(+21.9%) | $718.10M(+14.5%) | $2.53B(+7.6%) |
| Sep 2018 | - | $626.90M(+0.8%) | $2.36B(+2.9%) |
| Jun 2018 | - | $622.20M(+9.7%) | $2.29B(+3.2%) |
| Mar 2018 | - | $567.20M(+5.3%) | $2.22B(+6.6%) |
| Dec 2017 | $2.08B(+56.3%) | $538.82M(-3.8%) | $2.08B(+10.2%) |
| Sep 2017 | - | $559.93M(+1.7%) | $1.89B(+11.7%) |
| Jun 2017 | - | $550.31M(+27.8%) | $1.69B(+18.1%) |
| Mar 2017 | - | $430.54M(+24.1%) | $1.43B(+7.6%) |
| Dec 2016 | $1.33B(+6.3%) | $346.96M(-4.4%) | $1.33B(+9.5%) |
| Sep 2016 | - | $362.80M(+24.4%) | $1.21B(-2.4%) |
| Jun 2016 | - | $291.63M(-11.4%) | $1.24B(-4.1%) |
| Mar 2016 | - | $329.31M(+42.5%) | $1.30B(+3.7%) |
| Dec 2015 | $1.25B(+51.9%) | $231.08M(-41.1%) | $1.25B(+1.2%) |
| Sep 2015 | - | $392.42M(+13.8%) | $1.24B(+19.8%) |
| Jun 2015 | - | $344.86M(+21.6%) | $1.03B(+12.7%) |
| Mar 2015 | - | $283.55M(+31.4%) | $915.91M(+11.2%) |
| Dec 2014 | $823.92M(+10.9%) | $215.80M(+14.5%) | $823.92M(+2.6%) |
| Sep 2014 | - | $188.46M(-17.4%) | $803.21M(-5.7%) |
| Jun 2014 | - | $228.09M(+19.1%) | $851.55M(+9.0%) |
| Mar 2014 | - | $191.56M(-1.8%) | $781.56M(+5.2%) |
| Dec 2013 | $743.05M(+62.3%) | $195.09M(-17.6%) | $743.05M(+7.1%) |
| Sep 2013 | - | $236.80M(+49.8%) | $693.63M(+5.2%) |
| Jun 2013 | - | $158.10M(+3.3%) | $659.19M(+12.0%) |
| Mar 2013 | - | $153.05M(+5.1%) | $588.56M(+28.6%) |
| Dec 2012 | $457.71M(+323.1%) | $145.67M(-28.0%) | $457.71M(+71.7%) |
| Sep 2012 | - | $202.36M(+131.3%) | $266.64M(+4481.5%) |
| Jun 2012 | - | $87.48M(+294.0%) | $5.82M(+104.1%) |
| Mar 2012 | - | $22.20M(+148.9%) | -$141.98M(+30.8%) |
| Dec 2011 | -$205.16M(-110.5%) | -$45.40M(+22.3%) | -$205.16M(-18.9%) |
| Sep 2011 | - | -$58.46M(+3.1%) | -$172.53M(-18.0%) |
| Jun 2011 | - | -$60.32M(-47.2%) | -$146.17M(-33.4%) |
| Mar 2011 | - | -$40.98M(-220.7%) | -$109.58M(-12.4%) |
| Dec 2010 | -$97.47M(-31.5%) | -$12.78M(+60.2%) | -$97.47M(+21.5%) |
| Sep 2010 | - | -$32.09M(-35.3%) | -$124.10M(-33.0%) |
| Jun 2010 | - | -$23.72M(+17.8%) | -$93.30M(-8.7%) |
| Mar 2010 | - | -$28.88M(+26.7%) | -$85.84M(-15.8%) |
| Dec 2009 | -$74.10M(+14.1%) | -$39.41M(-2952.5%) | -$74.10M(-12.8%) |
| Sep 2009 | - | -$1.29M(+92.1%) | -$65.71M(+22.1%) |
| Jun 2009 | - | -$16.27M(+5.1%) | -$84.35M(+3.8%) |
| Mar 2009 | - | -$17.14M(+44.7%) | -$87.71M(-1.4%) |
| Dec 2008 | -$86.25M(+24.6%) | -$31.02M(-55.6%) | -$86.48M(-29.1%) |
| Sep 2008 | - | -$19.93M(-1.6%) | -$67.00M(+21.9%) |
| Jun 2008 | - | -$19.62M(-23.3%) | -$85.73M(+11.4%) |
| Mar 2008 | - | -$15.91M(-37.9%) | -$96.72M(+15.5%) |
| Dec 2007 | -$114.45M | -$11.53M(+70.2%) | -$114.45M(+16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$38.67M(-26.3%) | -$136.41M(-8.3%) |
| Jun 2007 | - | -$30.60M(+9.0%) | -$126.00M(-5.3%) |
| Mar 2007 | - | -$33.65M(-0.5%) | -$119.64M(-11.1%) |
| Dec 2006 | -$107.66M(-186.5%) | -$33.49M(-18.5%) | -$107.66M(-174.2%) |
| Sep 2006 | - | -$28.26M(-16.5%) | $145.15M(+4.4%) |
| Jun 2006 | - | -$24.25M(-11.9%) | $139.02M(+6.0%) |
| Mar 2006 | - | -$21.66M(-109.9%) | $131.10M(+5.4%) |
| Dec 2005 | $124.42M(+2103.7%) | $219.31M(+737.8%) | $124.42M(+236.8%) |
| Sep 2005 | - | -$34.39M(-6.9%) | -$90.92M(-37.7%) |
| Jun 2005 | - | -$32.17M(-13.5%) | -$66.01M(-42.0%) |
| Mar 2005 | - | -$28.34M(-813.1%) | -$46.49M(-923.4%) |
| Dec 2004 | $5.65M(+105.6%) | $3.97M(+141.9%) | $5.65M(+136.5%) |
| Sep 2004 | - | -$9.48M(+25.0%) | -$15.47M(+51.2%) |
| Jun 2004 | - | -$12.64M(-153.1%) | -$31.69M(+33.4%) |
| Mar 2004 | - | $23.79M(+238.8%) | -$47.60M(+52.3%) |
| Dec 2003 | -$99.99M(+18.0%) | -$17.14M(+33.3%) | -$99.78M(+14.9%) |
| Sep 2003 | - | -$25.70M(+10.0%) | -$117.27M(+5.2%) |
| Jun 2003 | - | -$28.56M(-0.6%) | -$123.74M(+1.1%) |
| Mar 2003 | - | -$28.38M(+18.1%) | -$125.14M(-2.6%) |
| Dec 2002 | -$121.95M(-42.3%) | -$34.63M(-7.6%) | -$121.95M(-4.3%) |
| Sep 2002 | - | -$32.18M(-7.4%) | -$116.91M(-8.2%) |
| Jun 2002 | - | -$29.95M(-18.9%) | -$108.03M(-12.3%) |
| Mar 2002 | - | -$25.19M(+14.9%) | -$96.17M(-12.2%) |
| Dec 2001 | -$85.68M(-239.0%) | -$29.59M(-27.0%) | -$85.68M(-30.1%) |
| Sep 2001 | - | -$23.29M(-28.8%) | -$65.88M(-13.4%) |
| Jun 2001 | - | -$18.09M(-22.9%) | -$58.07M(-32.4%) |
| Mar 2001 | - | -$14.71M(-50.3%) | -$43.87M(-16.6%) |
| Dec 2000 | -$25.28M(-6.2%) | -$9.79M(+36.8%) | -$37.64M(-31.8%) |
| Sep 2000 | - | -$15.49M(-298.9%) | -$28.55M(-57.2%) |
| Jun 2000 | - | -$3.88M(+54.2%) | -$18.16M(+19.9%) |
| Mar 2000 | - | -$8.48M(-1111.4%) | -$22.68M(+7.8%) |
| Dec 1999 | -$23.80M(-90.4%) | -$700.00K(+86.3%) | -$24.60M(+17.7%) |
| Sep 1999 | - | -$5.10M(+39.3%) | -$29.90M(-9.9%) |
| Jun 1999 | - | -$8.40M(+19.2%) | -$27.20M(-50.3%) |
| Mar 1999 | - | -$10.40M(-73.3%) | -$18.10M(-43.7%) |
| Dec 1998 | -$12.50M(+8.8%) | -$6.00M(-150.0%) | -$12.60M(-8.6%) |
| Sep 1998 | - | -$2.40M(-442.9%) | -$11.60M(-12.6%) |
| Jun 1998 | - | $700.00K(+114.3%) | -$10.30M(+29.9%) |
| Mar 1998 | - | -$4.90M(+2.0%) | -$14.70M(-5.8%) |
| Dec 1997 | -$13.70M(+20.8%) | -$5.00M(-354.5%) | -$13.90M(-3.7%) |
| Sep 1997 | - | -$1.10M(+70.3%) | -$13.40M(+19.8%) |
| Jun 1997 | - | -$3.70M(+9.8%) | -$16.70M(0.0%) |
| Mar 1997 | - | -$4.10M(+8.9%) | -$16.70M(+3.5%) |
| Dec 1996 | -$17.30M(-127.6%) | -$4.50M(-2.3%) | -$17.30M(-11.6%) |
| Sep 1996 | - | -$4.40M(-18.9%) | -$15.50M(-14.8%) |
| Jun 1996 | - | -$3.70M(+21.3%) | -$13.50M(-21.6%) |
| Mar 1996 | - | -$4.70M(-74.1%) | -$11.10M(-30.6%) |
| Dec 1995 | -$7.60M(+74.0%) | -$2.70M(-12.5%) | -$8.50M(+22.0%) |
| Sep 1995 | - | -$2.40M(-84.6%) | -$10.90M(+10.7%) |
| Jun 1995 | - | -$1.30M(+38.1%) | -$12.20M(+41.6%) |
| Mar 1995 | - | -$2.10M(+58.8%) | -$20.90M(+28.4%) |
| Dec 1994 | -$29.20M(+24.7%) | -$5.10M(-37.8%) | -$29.20M(+17.3%) |
| Sep 1994 | - | -$3.70M(+63.0%) | -$35.30M(+13.7%) |
| Jun 1994 | - | -$10.00M(+3.8%) | -$40.90M(-0.5%) |
| Mar 1994 | - | -$10.40M(+7.1%) | -$40.70M(-3.0%) |
| Dec 1993 | -$38.80M(-112.0%) | -$11.20M(-20.4%) | -$39.50M(-14.8%) |
| Sep 1993 | - | -$9.30M(+5.1%) | -$34.40M(-12.1%) |
| Jun 1993 | - | -$9.80M(-6.5%) | -$30.70M(-25.8%) |
| Mar 1993 | - | -$9.20M(-50.8%) | -$24.40M(-32.6%) |
| Dec 1992 | -$18.30M(-90.6%) | -$6.10M(-8.9%) | -$18.40M(-15.0%) |
| Sep 1992 | - | -$5.60M(-60.0%) | -$16.00M(-24.0%) |
| Jun 1992 | - | -$3.50M(-9.4%) | -$12.90M(-13.2%) |
| Mar 1992 | - | -$3.20M(+13.5%) | -$11.40M(-83.9%) |
| Dec 1991 | -$9.60M(-190.9%) | -$3.70M(-48.0%) | -$6.20M(+34.7%) |
| Sep 1991 | - | -$2.50M(-25.0%) | -$9.50M(-66.7%) |
| Jun 1991 | - | -$2.00M(-200.0%) | -$5.70M(-128.0%) |
| Mar 1991 | - | $2.00M(+128.6%) | -$2.50M(+24.2%) |
| Dec 1990 | -$3.30M | -$7.00M(-638.5%) | -$3.30M(-189.2%) |
| Sep 1990 | - | $1.30M(+8.3%) | $3.70M(+54.2%) |
| Jun 1990 | - | $1.20M(0.0%) | $2.40M(+100.0%) |
| Mar 1990 | - | $1.20M | $1.20M |
FAQ
- What is Regeneron Pharmaceuticals, Inc. annual operating income?
- What is the all-time high annual operating profit for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. annual operating profit year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. TTM operating profit year-on-year change?
What is Regeneron Pharmaceuticals, Inc. annual operating income?
The current annual operating profit of REGN is $4.09B
What is the all-time high annual operating profit for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high annual operating income is $8.99B
What is Regeneron Pharmaceuticals, Inc. annual operating profit year-on-year change?
Over the past year, REGN annual operating income has changed by -$141.50M (-3.34%)
What is Regeneron Pharmaceuticals, Inc. quarterly operating income?
The current quarterly operating profit of REGN is $1.08B
What is the all-time high quarterly operating profit for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high quarterly operating income is $3.35B
What is Regeneron Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
Over the past year, REGN quarterly operating income has changed by +$9.90M (+0.93%)
What is Regeneron Pharmaceuticals, Inc. TTM operating income?
The current TTM operating profit of REGN is $3.84B
What is the all-time high TTM operating profit for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high TTM operating income is $9.09B
What is Regeneron Pharmaceuticals, Inc. TTM operating profit year-on-year change?
Over the past year, REGN TTM operating income has changed by -$64.00M (-1.64%)